Astera Labs, Inc. (NASDAQ:ALAB) Stock Has Average Target Price of $348.33 According to Brokerages

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have received an average rating of “Moderate Buy” from the twenty-one research firms that are currently covering the company, MarketBeat Ratings reports. Eight research analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $348.33.

Several equities analysts recently weighed in on the stock. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Stifel Nicolaus increased their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Finally, Morgan Stanley raised their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the sale, the director directly owned 3,309 shares of the company’s stock, valued at $909,842.64. This represents a 73.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 396,059 shares of company stock valued at $122,605,660 in the last quarter. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALAB. BlackRock Inc. bought a new position in Astera Labs during the second quarter worth about $6,609,581,000. Atreides Management LP raised its position in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Van ECK Associates Corp lifted its stake in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after buying an additional 373,545 shares in the last quarter. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $1,061,791,000. Finally, Fred Alger Management LLC boosted its holdings in Astera Labs by 25.5% in the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after buying an additional 393,250 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Up 7.6%

Shares of Astera Labs stock opened at $389.80 on Friday. The business’s fifty day simple moving average is $313.22 and its 200 day simple moving average is $286.60. The firm has a market capitalization of $67.63 billion, a P/E ratio of 192.97 and a beta of 3.68. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the previous year, the firm earned $0.44 earnings per share. The business’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts predict that Astera Labs will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.